Cross Country Healthcare Q2 2024 Adj EPS $0.10 Misses $0.13 Estimate, Sales $339.77M Beat $334.76M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cross Country Healthcare (NASDAQ:CCRN) reported Q2 2024 earnings per share of $0.10, missing the analyst estimate of $0.13 by 23.08%. However, the company reported sales of $339.77 million, beating the estimate of $334.76 million by 1.50%. This represents a 37.16% decrease from the same period last year.
July 31, 2024 | 8:26 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cross Country Healthcare reported Q2 2024 EPS of $0.10, missing the $0.13 estimate, but sales of $339.77M beat the $334.76M estimate. Sales decreased by 37.16% YoY.
The miss on EPS is likely to negatively impact the stock price in the short term, despite the slight beat on sales. The significant YoY decrease in sales further adds to the negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100